SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla’s arm to expand consumer health business: Report

30 Nov 2017 Evaluate

Cipla’s consumer healthcare arm - Cipla Health has reportedly plans to revitalize its over-the-counter (OTC) consumer business through more in-house launches and brand acquisitions in the coming quarters.

The company is looking at new product launches in segments such as gastrointestinal, pain and analgesic, cough and cold and nutritional supplements. It is also actively looking at any kind of inorganic growth through mergers and acquisitions.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.


Cipla Share Price

1441.60 9.95 (0.70%)
09-Jul-2026 15:19 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.00
Dr. Reddys Labs. 1269.05
Cipla 1441.60
Zydus Lifesciences 1158.00
Lupin 2502.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: